Why the study?
What are the maternal and fetal risks associated with antipsychotic drug use during pregnancy?
What are the maternal and fetal risks associated with antipsychotic drug use during pregnancy?
Antipsychotic use in pregnancy is associated with adverse neonatal and pregnancy outcomes such as prematurity and abnormal birth weight, though malformation risk is not clearly evident and must be weighed against the risks of untreated maternal mental illness.
No takes yet. Share an insight, caveat, or question.
Antipsychotics in pregnancy warrant individualized risk-benefit assessment given neonatal concerns; leaves open need for prospective studies clarifying causality.
Galbally et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: